Diagnostics & Research
The Diagnostics & Research industry has a total of 51 stocks, with a combined market cap of $677.64 billion, total revenue of $163.57 billion and a weighted average PE ratio of 44.72.
Market Cap
677.64B
Revenue
163.57B
Profits
15.15B
PE Ratio
44.72
Profit Margin
9.26%
Dividend Yield
0.22%
51 Stocks
No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
---|---|---|---|---|---|---|
1 | TMO | Thermo Fisher Scientific Inc. | 184.93B | 0.33% | 1,400,373 | 43.21B |
2 | DHR | Danaher Corporation | 147.00B | 0.14% | 2,519,472 | 24.01B |
3 | IDXX | IDEXX Laboratories, Inc. | 51.77B | 0.96% | 309,227 | 4.04B |
4 | A | Agilent Technologies, Inc. | 35.44B | 5.28% | 3,886,156 | 6.79B |
5 | IQV | IQVIA Holdings Inc. | 32.08B | -0.04% | 1,161,481 | 15.70B |
6 | MTD | Mettler-Toledo International Inc. | 26.43B | -0.17% | 182,061 | 3.87B |
7 | NTRA | Natera, Inc. | 23.04B | 2.97% | 842,622 | 1.96B |
8 | LH | Labcorp Holdings Inc. | 22.88B | -1.44% | 298,408 | 13.48B |
9 | DGX | Quest Diagnostics Incorporated | 20.04B | -0.31% | 559,906 | 10.52B |
10 | WAT | Waters Corporation | 17.72B | 1.03% | 702,407 | 3.05B |
11 | ILMN | Illumina, Inc. | 15.24B | -0.37% | 1,144,399 | 4.28B |
12 | ICLR | ICON Public Limited Company | 13.61B | 0.59% | 495,315 | 8.09B |
13 | MEDP | Medpace Holdings, Inc. | 13.30B | -0.05% | 202,837 | 2.23B |
14 | RVTY | Revvity, Inc. | 10.36B | 0.72% | 790,336 | 2.80B |
15 | QGEN | Qiagen N.V. | 9.99B | -3.85% | 5,295,077 | 2.04B |
16 | EXAS | Exact Sciences Corporation | 8.89B | 0.51% | 2,273,845 | 2.94B |
17 | GH | Guardant Health, Inc. | 8.04B | 1.53% | 1,406,057 | 828.85M |
18 | CRL | Charles River Laboratories International, Inc. | 8.03B | 0.26% | 772,723 | 4.03B |
19 | RDNT | RadNet, Inc. | 5.52B | 0.70% | 523,416 | 1.91B |
20 | SHC | Sotera Health Company | 4.60B | -1.94% | 1,781,685 | 1.12B |
21 | WGS | GeneDx Holdings Corp. | 3.71B | -0.15% | 429,117 | 362.32M |
22 | HTFL | HeartFlow, Inc. | 2.69B | -7.65% | 380,615 | 136.17M |
23 | VCYT | Veracyte, Inc. | 2.36B | 4.68% | 974,333 | 479.13M |
24 | TWST | Twist Bioscience Corporation | 1.60B | -2.21% | 1,539,862 | 362.27M |
25 | NEOG | Neogen Corporation | 1.25B | 0.17% | 6,390,177 | 894.66M |
26 | GRAL | GRAIL, Inc. | 1.23B | 1.43% | 392,186 | 134.29M |
27 | OPK | OPKO Health, Inc. | 1.13B | - | 1,368,352 | 664.03M |
28 | NEO | NeoGenomics, Inc. | 931.38M | 1.84% | 2,545,195 | 689.19M |
29 | CDNA | CareDx, Inc | 697.81M | -1.35% | 1,802,997 | 340.83M |
30 | CSTL | Castle Biosciences, Inc. | 680.53M | 5.30% | 637,119 | 346.27M |
31 | FLGT | Fulgent Genetics, Inc. | 674.32M | 1.80% | 180,444 | 303.22M |
32 | MYGN | Myriad Genetics, Inc. | 578.74M | 4.89% | 1,198,176 | 832.90M |
33 | PSNL | Personalis, Inc. | 423.88M | - | 535,711 | 80.32M |
34 | XGN | Exagen Inc. | 214.32M | 1.99% | 248,616 | 58.86M |
35 | MDXH | MDxHealth SA | 171.76M | -3.34% | 166,828 | 98.95M |
36 | FONR | FONAR Corporation | 99.98M | 0.38% | 5,097 | 103.02M |
37 | PRE | Prenetics Global Limited | 95.85M | -0.62% | 21,074 | 41.52M |
38 | BNR | Burning Rock Biotech Limited | 91.52M | -0.23% | 10,921 | 72.11M |
39 | IMDX | Insight Molecular Diagnostics Inc. | 71.84M | 1.21% | 39,974 | 4.26M |
40 | BDSX | Biodesix, Inc. | 65.46M | -5.02% | 596,274 | 76.56M |
41 | NOTV | Inotiv, Inc. | 57.37M | -5.11% | 439,599 | 505.30M |
42 | PRPO | Precipio, Inc. | 25.02M | 1.25% | 12,277 | 21.24M |
43 | PRPH | ProPhase Labs, Inc. | 14.39M | 5.35% | 988,519 | 5.59M |
44 | ADVB | Advanced Biomed Inc. | 9.31M | 5.42% | 66,368 | - |
45 | BIAF | bioAffinity Technologies, Inc. | 6.89M | -1.39% | 257,675 | 7.68M |
46 | XWEL | XWELL, Inc. | 6.51M | 5.61% | 5,712 | 30.60M |
47 | MYNZ | Mainz Biomed N.V. | 5.61M | 0.62% | 48,005 | 893.99K |
48 | APDN | Applied DNA Sciences, Inc. | 4.12M | -1.85% | 49,452 | 3.74M |
49 | ISPC | iSpecimen Inc. | 3.99M | -2.73% | 754,325 | 5.91M |
50 | CHEK | Check-Cap Ltd. | 3.79M | -0.29% | 42,657 | - |
51 | NDRA | ENDRA Life Sciences Inc. | 3.05M | -1.46% | 15,830 | - |